They’re breathing a little easier at Mansfield-based Covidien Ltd. after the federal Food and Drug Administration approved the medical devices giant’s newest pulse oximeter.
Covidien‘s OxiMax SPD alert system answers the rising demand for continuous pulse oximetry monitors, especially for patients on powerful pain medication, company officials said.
The device uses an algorithm to detect patterns of reduced oxygen saturation in patients’ blood, which can indicate that a ventilator is compromised.